151 related articles for article (PubMed ID: 25966467)
21. A gene expression-based screening system for compounds influencing differentiation of mouse embryonic stem cells.
Kunisada Y; Shoji M; Hosoya M
J Biomol Screen; 2012 Feb; 17(2):140-51. PubMed ID: 21965112
[TBL] [Abstract][Full Text] [Related]
22. A short-term screening test for teratogens using differentiating neuroblastoma cells in vitro.
Mummery CL; van den Brink CE; van der Saag PT; de Laat SW
Teratology; 1984 Apr; 29(2):271-9. PubMed ID: 6740511
[TBL] [Abstract][Full Text] [Related]
23. A synthetic nanofibrillar matrix promotes in vitro hepatic differentiation of embryonic stem cells and induced pluripotent stem cells.
Yamazoe T; Shiraki N; Toyoda M; Kiyokawa N; Okita H; Miyagawa Y; Akutsu H; Umezawa A; Sasaki Y; Kume K; Kume S
J Cell Sci; 2013 Dec; 126(Pt 23):5391-9. PubMed ID: 24101719
[TBL] [Abstract][Full Text] [Related]
24. A Cancer Reprogramming Method Using MicroRNAs as a Novel Therapeutic Approach against Colon Cancer: Research for Reprogramming of Cancer Cells by MicroRNAs.
Miyazaki S; Yamamoto H; Miyoshi N; Wu X; Ogawa H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Konno M; Doki Y; Mori M; Ishii H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1394-401. PubMed ID: 25384704
[TBL] [Abstract][Full Text] [Related]
25. A standardized human embryoid body platform for the detection and analysis of teratogens.
Flamier A; Singh S; Rasmussen TP
PLoS One; 2017; 12(2):e0171101. PubMed ID: 28182681
[TBL] [Abstract][Full Text] [Related]
26. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
Ting S; Chen A; Reuveny S; Oh S
Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
[TBL] [Abstract][Full Text] [Related]
27. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis.
Hong SH; Lee JH; Lee JB; Ji J; Bhatia M
J Cell Sci; 2011 May; 124(Pt 9):1445-52. PubMed ID: 21486943
[TBL] [Abstract][Full Text] [Related]
28. A novel human stem cell-based biomarker assay for in vitro assessment of developmental toxicity.
Jamalpoor A; Hartvelt S; Dimopoulou M; Zwetsloot T; Brandsma I; Racz PI; Osterlund T; Hendriks G
Birth Defects Res; 2022 Nov; 114(19):1210-1228. PubMed ID: 35289129
[TBL] [Abstract][Full Text] [Related]
29. A Bmp Reporter Transgene Mouse Embryonic Stem Cell Model as a Tool to Identify and Characterize Chemical Teratogens.
Kugler J; Tharmann J; Chuva de Sousa Lopes SM; Kemler R; Luch A; Oelgeschläger M
Toxicol Sci; 2015 Aug; 146(2):374-85. PubMed ID: 26001961
[TBL] [Abstract][Full Text] [Related]
30. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models.
Kong CW; Akar FG; Li RA
Thromb Haemost; 2010 Jul; 104(1):30-8. PubMed ID: 20539906
[TBL] [Abstract][Full Text] [Related]
31. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
Webster WS; Brown-Woodman PD; Ritchie HE
Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
[TBL] [Abstract][Full Text] [Related]
32. Epithelial-mesenchymal transition in colonies of rhesus monkey embryonic stem cells: a model for processes involved in gastrulation.
Behr R; Heneweer C; Viebahn C; Denker HW; Thie M
Stem Cells; 2005; 23(6):805-16. PubMed ID: 15917476
[TBL] [Abstract][Full Text] [Related]
33. Hepatic differentiation of mouse embryonic stem cells and induced pluripotent stem cells during organoid formation in hollow fibers.
Amimoto N; Mizumoto H; Nakazawa K; Ijima H; Funatsu K; Kajiwara T
Tissue Eng Part A; 2011 Aug; 17(15-16):2071-8. PubMed ID: 21457096
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test.
Peters AK; Steemans M; Hansen E; Mesens N; Verheyen GR; Vanparys P
Toxicol Sci; 2008 Oct; 105(2):342-50. PubMed ID: 18593728
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of human embryonic stem cells and human induced pluripotent stem cells into steroid-producing cells.
Sonoyama T; Sone M; Honda K; Taura D; Kojima K; Inuzuka M; Kanamoto N; Tamura N; Nakao K
Endocrinology; 2012 Sep; 153(9):4336-45. PubMed ID: 22778223
[TBL] [Abstract][Full Text] [Related]
36. Exogenous activation of BMP-2 signaling overcomes TGFβ-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient-specific induced pluripotent stem cells.
Quarto N; Li S; Renda A; Longaker MT
Stem Cells; 2012 Dec; 30(12):2709-19. PubMed ID: 23037987
[TBL] [Abstract][Full Text] [Related]
37. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
[TBL] [Abstract][Full Text] [Related]
38. Thalidomide induced early gene expression perturbations indicative of human embryopathy in mouse embryonic stem cells.
Gao X; Sprando RL; Yourick JJ
Toxicol Appl Pharmacol; 2015 Aug; 287(1):43-51. PubMed ID: 26006729
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
[TBL] [Abstract][Full Text] [Related]
40. Human ES and iPS cells as cell sources for the treatment of Parkinson's disease: current state and problems.
Hwang DY; Kim DS; Kim DW
J Cell Biochem; 2010 Feb; 109(2):292-301. PubMed ID: 20014069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
